News
FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.
With artificial intelligence (AI) capabilities freeing up workers and driving billions in gains, pharmacy may soon see a 75% ...
To safely and successfully use artificial intelligence (AI) tools in the pharmacy, credentialing bodies and professional associations will need to validate these tools for the individual pharmacist, ...
But artificial intelligence on its own will never deny a claim, assures the insurer’s chief digital and technology officer ...
Specialty drugs are increasingly entering general medicine. Experts at Asembia’s AXS Summit say the trend will put a premium ...
The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...
The meeting was with a startup created by Flatiron Health veterans Josh Haimson and Ben Birnbaum. The duo had built the first ...
In 2025, pharmacy leaders are grappling with a billion-dollar question: how to deliver high-quality, patient-centered care amid financial strain, policy uncertainty, and rapid technological change.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results